Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
Clinical trial NCT04208958 · COMPLETED
Trial details
- NCT number
- NCT04208958
- Sponsor
- Vedanta Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-23
- Primary completion
- 2021-08-26
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.